Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2025 | Early intervention improves outcomes in prostate cancer

Robert Rutledge • 26 Feb 2025
EAU 2025
Genitourinary Cancer Prostate Cancer

Robert Rutledge, MD, FRCPC, Dalhousie University, Halifax, Canada, discusses the impact of early intervention in patients with prostate cancer. Patients who began Kegel exercises pre-operatively experienced superior long-term outcomes, and improved mental wellbeing, compared to patients who began post-operatively. This interview took place at the 2025 European Association of Urology (EAU) Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Robert Rutledge

International collaboration for PC-PEP in prostate cancer care
1:30
International collaboration for PC-PEP in prostate cancer care
Robert Rutledge • 26 Feb 2026
2026 updates in PC-PEP, a six-month home program for prostate cancer
2:35
2026 updates in PC-PEP, a six-month home program for prostate cancer
Robert Rutledge • 26 Feb 2026
An overview of the Health Care Professionals Patient Empowerment Program
1:18
An overview of the Health Care Professionals Patient Empowerment Program
Robert Rutledge • 26 Feb 2026
Prioritizing mental & physical health in patients with prostate cancer
0:47
Prioritizing mental & physical health in patients with prostate cancer
Robert Rutledge • 26 Feb 2025

Related Videos

Enzalutamide outcomes & duration predictors in mHSPC: ARCHES post hoc analyses
3:04
Enzalutamide outcomes & duration predictors in mHSPC: ARCHES post hoc analyses
Andrew Armstrong • 3 Jun 2026
Chemo-IO in neuroendocrine or aggressive variant metastatic prostate cancer
2:24
Chemo-IO in neuroendocrine or aggressive variant metastatic prostate cancer
Andrew Armstrong • 3 Jun 2026
Treatment sequencing after EV plus pembrolizumab in metastatic bladder cancer
2:10
Treatment sequencing after EV plus pembrolizumab in metastatic bladder cancer
Tian Zhang • 1 Jun 2026
Highlights in ADCs for bladder cancer at ASCO 2026
1:29
Highlights in ADCs for bladder cancer at ASCO 2026
Tian Zhang • 1 Jun 2026
The content of VJOncology is intended for healthcare professionals